KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer
about
The molecular background of mucinous carcinoma beyond MUC2MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 CellsCharacterization of rare transforming KRAS mutations in sporadic colorectal cancer.KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomasBRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients.Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditionsKRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patientsEffectors of epidermal growth factor receptor pathway: the genetic profiling ofKRAS, BRAF, PIK3CA, NRAS mutations in colorectal cancer characteristics and personalized medicine.Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stagesThe mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese PatientsPrevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancerMolecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse modelMutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTENMolecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancerDovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association.Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy.KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung.Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort.Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China.Mutations in KRAS codon 12 predict poor survival in Chinese patients with metastatic colorectal cancer.Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population.Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer.Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma.PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.Mutation Status and Immunohistochemical Correlation of , and in 260 Chinese Colorectal and Gastric Cancers
P2860
Q28083904-C2987373-9D85-4CCB-B921-6FB5A45B22A1Q28547840-43980627-5DE1-4A45-B982-1B0C8BE122A1Q33727871-24DC6328-3EC4-471C-8ACD-AF395E556951Q33948020-DFE621D7-DC51-4CCB-AF5A-BCED76B29151Q34517338-0CE39325-0852-44EE-8411-F2D50702DE20Q34565052-866E0118-CA78-4CCD-8A7D-DDDA79D8F0A8Q35045790-0A96391B-B409-4930-88C9-13ED4B6BA912Q35067570-7465C70F-4D96-4ADE-9917-9355A07B87ABQ35579056-75137CDD-85C9-4B5C-A6C2-B737724EDB31Q35782746-0B2CC586-0483-43E6-85BC-87E37F0EDF95Q35932262-A1F2BAE2-8DF0-4212-812F-5B793C166021Q36085837-82EDEC04-9821-4865-AFE3-AE2FD2954480Q36393095-EDC124B1-A9AD-4D43-A1E7-3EC10E380935Q36531671-D7EABABB-D803-4D9B-A283-055CCAF48B22Q37215789-49CE5B39-B98D-4BC8-AFA6-8FE0A8750430Q37317549-6AF7344B-B5A4-4B14-B2FF-963287353E92Q37439924-AF83DFD1-20BC-473F-AABF-D22647C563B4Q37525272-606195CC-03A1-450C-86B5-4258F1F8F52AQ37608405-CBFD74A2-FA65-465F-AFC6-C8F99E534627Q37717519-F178C487-D762-4B15-91CD-A73CAB16860EQ38409303-C2A705E1-0EC5-439C-A581-15CCE2650489Q38950805-ECA0DD01-95FD-49E6-ACE8-DAE966B2E0C8Q40072841-3CA21701-8BCA-49B2-B76E-5E9D7773A427Q40196309-9D17E481-59C8-4A87-86CD-CBA92F0625C7Q40671461-B33A9DA2-F625-4167-8593-8180758163C1Q40681892-323CD9A5-29FA-4D53-B9EB-DBEDCAB3B4CDQ41410508-D6637E5C-361F-47B0-9B23-8D1B206BBE58Q42725637-89995C60-BAA9-4F98-A35E-9B66B19BB20AQ45334548-CF6F2B7A-6F6D-4A75-855B-06942F744C76Q45711137-E650BAD6-7C90-498B-A113-B5E73A7E61D0Q45764349-9CC2F0AA-151B-4232-AF24-75647D20B597Q49307611-F5F58C99-BC61-46E3-B758-39E8820F7952Q49679318-386DBDB0-CB21-49A5-A700-78BF7B623D87Q51711213-B51B9C41-2D12-46BB-BD9C-3D241A25CEB4Q53235759-19F4AEB5-0A35-402C-840E-DCABE8E8F8EBQ53548338-5EE9381C-6780-4C66-BE9B-37941F764BD8Q54334205-0D626BD1-987D-4BD1-9934-F27A3C559C08Q55518346-FAB57476-8871-4565-9992-1F7D39313A85Q58707595-D9B90B7F-EC36-4A4F-A13B-86B34C4A5EE1
P2860
KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@ast
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@en
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@nl
type
label
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@ast
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@en
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@nl
prefLabel
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@ast
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@en
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@nl
P2093
P2860
P1433
P1476
KRAS, BRAF and PIK3CA mutation ...... atients with colorectal cancer
@en
P2093
Jinling Tang
Junhua Zhou
Yafang Huang
Zuyao Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0036653
P407
P577
2012-05-07T00:00:00Z